Accapezzato D, Caccavale R, Paroli MP, et al. Advances in the pathogenesis and treatment of systemic lupus erythematosus. Int J Mol Sci. 2023;24(7):6578. https://doi.org/10.3390/ijms24076578.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ba X, Wang H, Huang Y, et al. Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway. J Ethnopharmacol. 2023;12(309):116274. https://doi.org/10.1016/j.jep.2023.116274.

Article  CAS  Google Scholar 

Blair HA, Duggan ST. Belimumab: a review in systemic lupus erythematosus. Drugs. 2018;78(3):355–66. https://doi.org/10.1007/s40265-018-0872-z.

Article  CAS  PubMed  Google Scholar 

Ceeraz S, Sergent PA, Plummer SF, et al. VISTA deficiency accelerates the development of fatal murine lupus nephritis. Arthritis Rheumatol. 2017;69(4):814–25. https://doi.org/10.1002/art.40020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen XC, Wu D, Wu HL, et al. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway. Lupus Sci Med. 2022;9(1):e000611. https://lupus.bmj.com/content/9/1/e000611

Article  PubMed  PubMed Central  Google Scholar 

Cildir G, Low KC, Tergaonkar V. Noncanonical NF-κB signaling in health and disease. Trends Mol Med. 2016;22(5):414–29. https://doi.org/10.1016/j.molmed.2016.03.002.

Article  CAS  PubMed  Google Scholar 

Dingyi Y, Yuxin Z, Wanmei L, et al. Transcriptome profiling reveals transcriptional regulation of VISTA in T cell activation. Mol Immunol. 2023;157:101–11. https://doi.org/10.1016/j.molimm.2023.03.021.

Article  CAS  Google Scholar 

ElTanbouly MA, Croteau W, Noelle RJ, et al. VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity. Semin Immunol. 2019;42:101308. https://doi.org/10.1016/j.smim.2019.101308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

ElTanbouly MA, Zhao Y, Nowak E, et al. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance. Science. 2020;367(6475):eaay0524. https://doi.org/10.1126/science.aay0524.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher CE, Ahmad SA, Fitch PM, et al. FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression. Cell Biol Int. 2005;29(10):868–76. https://doi.org/10.1016/j.cellbi.2005.07.002.

Article  CAS  PubMed  Google Scholar 

Gallucci S, Meka S, Gamero AM. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity. Cytokine. 2021 Oct;146:155633. https://doi.org/10.1016/j.cyto.2021.155633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gardet A, Pellerin A, McCarl CA, et al. Effect of in vivo hydroxychloroquine and ex vivo anti-BDCA2 mAb treatment on pDC IFNα production from patients affected with cutaneous lupus erythematosus. Front Immunol. 2019;10(275):3389.

Google Scholar 

Han X, Vesely MD, Yang W, et al. PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Sci Transl Med. 2019;11(522):eaax1159. https://doi.org/10.1126/scitranslmed.aax1159.

Article  CAS  PubMed  Google Scholar 

Hillion S, Arleevskaya MI, Blanco P, et al. The innate part of the adaptive immune system. Clin Rev Allergy Immunol. 2020 Apr;58(2):151–4. https://doi.org/10.1007/s12016-019-08740-1.

Article  PubMed  Google Scholar 

Hosseinkhani N, Derakhshani A, Shadbad MA, et al. The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: lessons learned and the road ahead. Front Immunol. 2021 May;19(12):676181. https://doi.org/10.3389/fimmu.2021.676181.

Article  CAS  Google Scholar 

Hu X, Qie C, Jiang J, Xie X, et al. M351-0056 is a novel low MW compound modulating the actions of the immune-checkpoint protein VISTA. Br J Pharmacol. 2021;178(6):1445–58. https://doi.org/10.1111/bph.15357.

Article  CAS  PubMed  Google Scholar 

Jiang J, Zhao M, Chang C, et al. Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol. 2020;59(2):248–72. https://doi.org/10.1007/s12016-020-08798-2.

Article  CAS  PubMed  Google Scholar 

Kegerreis BJ, Catalina MD, Geraci NS, et al. Genomic identification of low-density granulocytes and analysis of their role in the pathogenesis of systemic lupus erythematosus. J Immunol. 2019;202(11):3309–17. https://doi.org/10.4049/jimmunol.1801512.

Article  CAS  PubMed  Google Scholar 

Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81–96. https://doi.org/10.7326/aitc202006020.

Article  PubMed  Google Scholar 

Klavdianou K, Lazarini A. Fanouriakis A Targeted biologic therapy for systemic lupus erythematosus: emerging pathways and drug pipeline. Biodrugs. 2020;34(2):133–47. https://doi.org/10.1007/s40259-020-00405-2.

Article  CAS  PubMed  Google Scholar 

Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III interferons. Immunity. 2019;50(4):907–23. https://doi.org/10.1016/j.immuni.2019.03.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang CL, Jiang H, Feng W, et al. Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands+ macrophages via activating IL-4/STAT6/PD-L2 signaling. Front Immunol. 2021;12:683249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Zhuang S. Role of receptor tyrosine kinase signaling in renal fibrosis. Int J Mol Sci. 2016;17(5):972. https://doi.org/10.3390/ijms17060972.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Huang X, Ye H, et al. Lupus Recipe inhibits cGVHD-induced lupus nephritis in mice and promote renal LC3-associated autophagy. Immun Inflamm Dis. 2023;(11, 3):e815. https://doi.org/10.1002/iid3.815.

Mazewski C, Perez RE, Fish EN, et al. Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways. Front Immunol. 2020;11:606456. https://doi.org/10.3389/fimmu.2020.606456.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta N, Maddineni S, Mathews II, et al. Structure and functional binding epitope of V-domain Ig suppressor of T cell activation. Cell Rep. 2019;28(10):2509–2516.e5. https://doi.org/10.1016/j.celrep.2019.07.073.

Article  CAS  PubMed  Google Scholar 

Mulati K, Hamanishi J, Matsumura N, et al. VISTA expressed in tumour cells regulates T cell function. Br J Cancer. 2019 Jan;120(1):115–27. https://doi.org/10.1038/s41416-018-0313-5.

Article  CAS  PubMed  Google Scholar 

Murphy G, Isenberg DA. New therapies for systemic lupus erythematosus - past imperfect, future tense. Nat Rev Rheumatol. 2019;15(7):403–12. https://doi.org/10.1038/s41584-019-0235-5.

Article  PubMed  Google Scholar 

Nowak EC, Lines JL, Varn FS, et al. Immunoregulatory functions of VISTA. Immunol Rev. 2017;276(1):66–79. https://doi.org/10.1111/imr.12525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan L, Lu MP, Wang JH, et al. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19–30. https://doi.org/10.1007/s12519-019-00229-3.

Article  PubMed  Google Scholar 

Ruiz-Irastorza G, Bertsias G. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatology (Oxford). 2020;59(Suppl5):v69–81. https://doi.org/10.1093/rheumatology/keaa403.

Article  CAS  PubMed  Google Scholar 

Samotij D, Reich A. Biologics in the treatment of lupus erythematosus: a critical literature review. Biomed Res Int. 2019;2019:8142368. https://doi.org/10.1155/2019/8142368.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato S, Zhang XK, Matsuoka N, et al. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse. Lupus Sci Med. 2023;10(1):e000870. https://doi.org/10.1136/lupus-2022-000870.

Article  PubMed  PubMed Central  Google Scholar 

Sergent PA, Plummer SF, Pettus J, et al. Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice. Lupus. 2018;27(2):210–6. https://doi.org/10.1177/0961203317716322.

Article  CAS  PubMed  Google Scholar 

Singh JA, Shah NP, Mudano AS. Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021 Feb 25;2(2):CD010668. https://doi.org/10.1002/14651858.cd010668.pub2.

Article  PubMed